FI96480B - Förfarande för framställning av multigranulat-depottablett - Google Patents

Förfarande för framställning av multigranulat-depottablett Download PDF

Info

Publication number
FI96480B
FI96480B FI873407A FI873407A FI96480B FI 96480 B FI96480 B FI 96480B FI 873407 A FI873407 A FI 873407A FI 873407 A FI873407 A FI 873407A FI 96480 B FI96480 B FI 96480B
Authority
FI
Finland
Prior art keywords
granules
tablets
long
acting
tablet
Prior art date
Application number
FI873407A
Other languages
English (en)
Finnish (fi)
Other versions
FI873407A (sv
FI873407A0 (sv
FI96480C (sv
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of FI873407A0 publication Critical patent/FI873407A0/sv
Publication of FI873407A publication Critical patent/FI873407A/sv
Publication of FI96480B publication Critical patent/FI96480B/sv
Application granted granted Critical
Publication of FI96480C publication Critical patent/FI96480C/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Vending Machines For Individual Products (AREA)
  • Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI873407A 1986-08-06 1987-08-05 Förfarande för framställning av multigranulat-depottablett FI96480C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18341486 1986-08-06
JP61183414A JPH0780754B2 (ja) 1986-08-06 1986-08-06 多顆粒型持続性錠剤

Publications (4)

Publication Number Publication Date
FI873407A0 FI873407A0 (sv) 1987-08-05
FI873407A FI873407A (sv) 1988-02-07
FI96480B true FI96480B (sv) 1996-03-29
FI96480C FI96480C (sv) 1996-07-10

Family

ID=16135361

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873407A FI96480C (sv) 1986-08-06 1987-08-05 Förfarande för framställning av multigranulat-depottablett

Country Status (11)

Country Link
EP (1) EP0255725B1 (sv)
JP (1) JPH0780754B2 (sv)
KR (1) KR950002148B1 (sv)
AT (1) ATE102480T1 (sv)
CA (1) CA1315680C (sv)
DE (1) DE3789258T2 (sv)
DK (1) DK175798B1 (sv)
ES (1) ES2050653T3 (sv)
FI (1) FI96480C (sv)
NO (1) NO178134C (sv)
PH (1) PH25545A (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
AU683092B2 (en) * 1993-10-12 1997-10-30 Mitsubishi-Tokyo Pharmaceuticals, Inc. Tablet containing enteric granules
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
FR2795962B1 (fr) 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
WO2002043694A2 (en) 2000-11-28 2002-06-06 Fmc Corporation Edible pga(propylene glycol alginate) coating composition
US7255876B2 (en) 2001-07-27 2007-08-14 Astellas Pharma, Inc. Composition comprises sustained-release fine particles and manufacturing method thereof
FR2837100B1 (fr) 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
JPS5873359A (ja) * 1981-10-27 1983-05-02 旭化成株式会社 医薬錠剤の製造方法

Also Published As

Publication number Publication date
ATE102480T1 (de) 1994-03-15
FI873407A (sv) 1988-02-07
NO178134C (no) 1996-01-31
DK175798B1 (da) 2005-02-28
CA1315680C (en) 1993-04-06
EP0255725A3 (en) 1991-01-30
EP0255725A2 (en) 1988-02-10
EP0255725B1 (en) 1994-03-09
PH25545A (en) 1991-08-08
NO873273L (no) 1988-02-08
DK407287A (da) 1988-02-07
JPS6339811A (ja) 1988-02-20
KR880002510A (ko) 1988-05-09
DE3789258D1 (de) 1994-04-14
NO178134B (no) 1995-10-23
NO873273D0 (no) 1987-08-05
DE3789258T2 (de) 1994-08-11
ES2050653T3 (es) 1994-06-01
KR950002148B1 (ko) 1995-03-14
FI873407A0 (sv) 1987-08-05
FI96480C (sv) 1996-07-10
DK407287D0 (da) 1987-08-05
JPH0780754B2 (ja) 1995-08-30

Similar Documents

Publication Publication Date Title
AU737738B2 (en) Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
TWI778983B (zh) 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
RU2531553C2 (ru) Таблетированная многоединичная лекарственная форма, способ её получения, упаковка и способ ингибирования секреции желудочной кислоты и/или лечения желудочно-кишечных воспалительных заболеваний
EP0281200B1 (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
EP1561458B1 (en) Rapidly disintegrable solid preparation
CN1119993C (zh) 醋氨酚、假麻黄碱、扑尔敏和可有可无的美沙芬的旋转制粒及包衣
EP0519099A1 (en) Direct compression cyclophosphamide tablet
EP1842534A1 (en) Metoprolol succinate extended release tablets and methods for their preparation
EP2448561B1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
KR20100119539A (ko) 다이펜하이드라민을 포함하는 경구 분해성 정제
EP1967211A1 (en) Method of producing solid preparation disintegrating in the oral cavity
JP2003502359A (ja) 新規製剤
US20110195120A2 (en) Sustained Release Pharmaceutical Composition Containing Metformin Hydrochloride
FI96480B (sv) Förfarande för framställning av multigranulat-depottablett
EP2197428B1 (en) Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof
JP2002509882A (ja) フルオキセチンおよびそのエナンチオマーの安定した投薬剤形
CN104363896A (zh) 恩替卡韦的药物组合物及制造方法
JPH03500288A (ja) 徐放性ニフェジピン製剤
WO2006123213A1 (en) Modified release formulations of gliclazide
GR1009644B (el) Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μετφορμινη και μεθοδος για την παρασκευη αυτου
CN105407875A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
CN112057429B (zh) 雷西纳德控释药物组合物
CA1229552A (en) Cimetidine compositions
CA1266235A (en) Tablet composition for drug combinations
JPH0253721A (ja) 被覆顆粒を含む錠剤

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: EISAI CO., LTD.

MA Patent expired